|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 12.81 HKD | +0.63% |
|
-2.95% | +5.35% |
| 05-13 | HBM Holdings says independent non-executive director receives case filing notice from CSRC | RE |
| 05-08 | HBM's Anti-Tumor Drug Application Gets FDA Clearance for Phase 1 Trial | MT |
| Capitalization | 1.37B 10.72B 1.18B 1.08B 1.03B 1.88B 131B 1.92B 12.93B 5B 62.37B 5.14B 5.03B 217B | P/E ratio 2026 * |
23.4x | P/E ratio 2027 * | 17.1x |
|---|---|---|---|---|---|
| Enterprise value | 1.37B 10.72B 1.18B 1.08B 1.03B 1.88B 131B 1.92B 12.93B 5B 62.37B 5.14B 5.03B 217B | EV / Sales 2026 * |
6.78x | EV / Sales 2027 * | 6.74x |
| Free-Float |
76.82% | Yield 2026 * |
-
| Yield 2027 * | - |
| 1 day | +0.63% | ||
| 1 week | -2.95% | ||
| Current month | -1.54% | ||
| 1 month | -11.53% | ||
| 3 months | +9.58% | ||
| 6 months | -8.70% | ||
| Current year | +5.35% |
| 1 week | 12.49 |  | 13.52 |
| 1 month | 12.49 | | 14.98 |
| Current year | 10.61 | | 15.2 |
| 1 year | 7.52 | | 17.98 |
| 3 years | 1.01 | | 17.98 |
| 5 years | 0.87 | | 17.98 |
| 10 years | 0.87 | | 17.98 |
| Manager | Title | Age | Since |
|---|---|---|---|
Jing Song Wang
CEO | Chief Executive Officer | 62 | 19/07/2016 |
Adam Zong
PSD | President | - | 15/04/2026 |
You Chen Chen
DFI | Director of Finance/CFO | - | 08/04/2025 |
| Director | Title | Age | Since |
|---|---|---|---|
Jing Song Wang
CHM | Chairman | 62 | 19/07/2016 |
Robert Kamen
BRD | Director/Board Member | 81 | 30/11/2016 |
Yi Ping Rong
BRD | Director/Board Member | 49 | 04/05/2022 |
| Change | 5d. change | 1-year change | 3-years change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | +0.63% | -2.95% | +38.19% | +567.19% | 1.36B | |
| -2.05% | -2.33% | +19.36% | -7.02% | 72.53B | |
| -1.37% | +1.24% | +53.40% | +174.37% | 53.4B | |
| -2.07% | +41.90% | +41.90% | +41.90% | 44.97B | |
| +0.72% | -18.28% | -58.91% | -68.18% | 34.1B | |
| +0.83% | -0.26% | +55.98% | -38.13% | 28.25B | |
| -1.98% | -9.77% | +107.36% | -62.35% | 19.85B | |
| -2.38% | -3.30% | +51.86% | +43.97% | 19.5B | |
| -5.42% | -8.89% | +64.16% | +104.74% | 19.21B | |
| +0.55% | +1.33% | +43.74% | +85.61% | 16.23B | |
| Average | -1.25% | -4.80% | +41.71% | +84.21% | 30.94B | |
| Weighted average by Cap. | -1.44% | -4.16% | +35.07% | +35.80% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 202M 1.58B 174M 159M 152M 278M 19.38B 283M 1.91B 738M 9.2B 758M 742M 32.05B | 203M 1.59B 175M 160M 152M 279M 19.48B 284M 1.92B 742M 9.25B 762M 746M 32.22B |
| Net income | 62M 485M 53.35M 48.78M 46.54M 85.32M 5.95B 86.73M 585M 226M 2.82B 233M 228M 9.84B | 83.58M 654M 71.92M 65.76M 62.74M 115M 8.02B 117M 789M 305M 3.81B 314M 307M 13.26B |
| Net Debt | - | - |
| Date | Price | Change | Volume |
|---|---|---|---|
| 15/05/26 | 12.81 $ | +0.63% | 2,817,000 |
| 14/05/26 | 12.73 $ | -0.47% | 2,776,000 |
| 13/05/26 | 12.79 $ | -2.52% | 4,058,700 |
| 12/05/26 | 13.12 $ | -2.81% | 1,730,316 |
| 11/05/26 | 13.50 $ | +2.27% | 3,350,400 |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
Annual profits - Rate of surprise
- Stock Market
- Equities
- 2142 Stock
Select your edition
All financial news and data tailored to specific country editions
MarketScreener is also available in this country: United States.
Switch edition